Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 Dec;100(12):1091-7.
doi: 10.1007/s00347-003-0884-1.

[Measuring patient's quality of life in ophthalmology]

[Article in German]
C Hirneiss  1 , A S Neubauer, U Welge-Lüssen, K Eibl, A Kampik
Affiliations
Comparative Study

[Measuring patient's quality of life in ophthalmology]

[Article in German]
C Hirneiss et al. Ophthalmologe. 2003 Dec.

Abstract

Background: The assessment of patient's quality of life is not only of vital importance for clinical trials of new therapies but also becomes more and more implemented into daily clinical therapeutical decisions.

Methods: Different methods for evaluating quality of life are available. A well-known questionnaire for measuring global quality of life is the Short Form 36 (SF 36). However, in ophthalmology more specific instruments for measuring visual quality of life are needed. We review the usefulness of specific questionnaires such as the Visual Function 14 (VF-14) or the National Eye Institute Visual Function Questionnaire (NEI-VFQ) in their application to common ophthalmologic diseases such as cataract, age-related macular degeneration and glaucoma. Studies applying these methods were identified by a search in the Medline database.

Results: Several instruments to measure visual life quality in ophthalmologic patients are available. Internal consistency and validity are shown.

Conclusions: Evaluating visual quality of life is an important parameter for assessing ophthalmologic diseases and the value of different therapies. It is an important outcome variable in clinical studies. Furthermore, individual visual quality of life should be considered in individual therapeutic decisions and helps to assess the economic effect of current and new therapies.

PubMed Disclaimer

References

    1. Arch Ophthalmol. 1994 May;112(5):630-8 - PubMed
    1. Ophthalmology. 1999 Jan;106(1):165-8 - PubMed
    1. Am J Ophthalmol. 1999 Jul;128(1):38-44 - PubMed
    1. Br J Ophthalmol. 1999 Oct;83(10):1115-20 - PubMed
    1. J Clin Epidemiol. 1998 Oct;51(10):827-35 - PubMed